Stratification of Patient With Carotid Disease - Trial NCT03495830
Access comprehensive clinical trial information for NCT03495830 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Belgrade and is currently status unknown. The study focuses on Carotid Artery Stenosis. Target enrollment is 270 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Belgrade
Timeline & Enrollment
N/A
Mar 29, 2018
Sep 01, 2022
Primary Outcome
Combined stroke, transitory ischemic attach and retinal transitory ischemic attach
Summary
Introduction: Taxinomisis trial is part of the Taxinomisis project. The concept of the
 Taxinomisis project is to stratify carotid artery disease relying on new modern data
 corresponding to contemporary patients based on information from longitudinal studies.
 Taxinomisis trial will validate this tool and adjust such stratification. Initial step of the
 project is characterization of symptomatic and asymptomatic carotid atherosclerotic plaque
 lesions, identification of risk and susceptibility factors through the exploitation of
 longitudinal cohort data and multiomics and disintegration of carotid artery disease
 phenotypes into endotypes through joint modeling of multipleomics data sets and systems
 medicine approaches. Finally such stratification model will be validated and adjusted in the
 Taxinomisis clinical trial.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT03495830
Non-Device Trial

